biological · Product Intelligence

Sacituzumab Tirumotecan
Pipeline Intelligence

Sacituzumab Tirumotecan: 4 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
4Indexed trials
▦
1Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT06788912Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06952504Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT06966700Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT07216703Merck Sharp & Dohme LLC · parkinsonsPHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.